We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.
- Authors
Marzolini, Catia; Kuritzkes, Daniel R.; Marra, Fiona; Boyle, Alison; Gibbons, Sara; Flexner, Charles; Pozniak, Anton; Boffito, Marta; Waters, Laura; Burger, David; Back, David; Khoo, Saye
- Abstract
Nirmatrelvir-ritonavir (NMV/r) is increasingly available for use in high-risk patients with mild to moderate COVID-19 ([1]) who are likely to be receiving other medications. Interactions between NMV/r and comedications can be screened using specialized resources, such as the National Institutes of Health COVID-19 treatment guidelines ([3]) or the University of Liverpool's website on COVID-19 drug interactions ([4]).
- Publication
Annals of Internal Medicine, 2022, Vol 175, Issue 5, p744
- ISSN
0003-4819
- Publication type
Editorial
- DOI
10.7326/M22-0281